Reveals that neuropeptide Y receptor neurons drive pain in Parkinson’s disease, indicating a potential target for treatment.
BACKGROUND: Pain is a common and debilitating non-motor symptom of Parkinson's disease (PD), yet its underlying neural mechanisms remain poorly defined. OBJECTIVES: The aim was to test whether neuropeptide Y Y1 receptor (Npy1r)-expressing parabrachial neuronsdrive PD-associated pain. METHODS: In a unilateral 6 hydroxydopamine (6-OHDA) mouse model, pain-related behaviors, neuronal activation, and intrinsic excitability of parabrachial nucleus (PBN) neurons were assessed using behavioral assays, fluorescence in situ hybridization, and ex vivo whole-cell patch-clamp electrophysiology. Cell type-specific chemogenetic inhibition. RESULTS: Following 6-OHDA injection, mice developed robust multimodal hypersensitivity accompanied by increased recruitment of Npy1r-expressing PBN neurons. Chemogenetic silencing of Npy1r-expressing PBN neurons abolished PD-associated hypersensitivity, whereas activation induced pain-like behaviors in naïve mice. CONCLUSIONS: Npy1r-expressing PBNs are a discrete supraspinal population that drives pain in a preclinical model of PD.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: